DK55888D0 - Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose - Google Patents

Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose

Info

Publication number
DK55888D0
DK55888D0 DK055888A DK55888A DK55888D0 DK 55888 D0 DK55888 D0 DK 55888D0 DK 055888 A DK055888 A DK 055888A DK 55888 A DK55888 A DK 55888A DK 55888 D0 DK55888 D0 DK 55888D0
Authority
DK
Denmark
Prior art keywords
hyperlipidaemia
atherosclerosis
derivatives
prophylaxy
pyridoxin
Prior art date
Application number
DK055888A
Other languages
English (en)
Other versions
DK55888A (da
Inventor
Ulrich Speck
Original Assignee
Ulrich Speck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulrich Speck filed Critical Ulrich Speck
Publication of DK55888D0 publication Critical patent/DK55888D0/da
Publication of DK55888A publication Critical patent/DK55888A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK055888A 1987-02-18 1988-02-03 Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose DK55888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873705549 DE3705549A1 (de) 1987-02-18 1987-02-18 Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose

Publications (2)

Publication Number Publication Date
DK55888D0 true DK55888D0 (da) 1988-02-03
DK55888A DK55888A (da) 1988-08-19

Family

ID=6321453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK055888A DK55888A (da) 1987-02-18 1988-02-03 Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose

Country Status (12)

Country Link
EP (1) EP0282696B1 (da)
JP (2) JPH0710777B2 (da)
KR (1) KR950009094B1 (da)
AT (1) ATE82125T1 (da)
CA (1) CA1340246C (da)
DE (2) DE3705549A1 (da)
DK (1) DK55888A (da)
EG (1) EG18335A (da)
ES (1) ES2052609T3 (da)
GR (1) GR3006693T3 (da)
HU (1) HUT47850A (da)
ZA (1) ZA88577B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AU1444600A (en) * 1998-10-09 2000-05-01 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
AU763464B2 (en) 1999-03-08 2003-07-24 Medicure Inc. Pyridoxal analogues for vitamin B-6 disorders
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
CA2383252A1 (en) 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
JP2003525303A (ja) 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド 心臓保護ホスホン酸塩およびマロン酸塩
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
EP1610783A2 (en) * 2003-03-27 2006-01-04 Medicure Inc. Modulation of cell death
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
JP2008526783A (ja) * 2005-01-05 2008-07-24 メディキュア・インターナショナル・インコーポレーテッド トリグリセリドレベルを調節するための化合物及び方法
FR3038227B1 (fr) * 2015-06-30 2018-08-17 Assistance Publique - Hopitaux De Paris Formulation effervescente a base de pyridoxal-5-phosphate
WO2020003363A1 (ja) * 2018-06-25 2020-01-02 学校法人近畿大学 ニコチン摂取の影響による血管の劣化を防止するための健康食品または医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3373E (fr) 1904-02-26 1904-10-27 Joseph Louis Felix Garrigou Procédé de traitement des vidanges et déchets organiques, et appareil d'ensemble permettant sa mise en oeuvre
FR6707M (da) * 1966-04-29 1969-02-17
GB1070120A (en) * 1966-05-06 1967-05-24 Tanabe Seiyaku Co Pyridoxine derivative and the preparation thereof
FR7238M (da) * 1968-03-27 1969-09-01
FR2035765A1 (en) * 1969-03-06 1970-12-24 Inst Rech Scient Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
JPS5347110B2 (da) * 1971-11-02 1978-12-19
FR2176509A2 (en) * 1972-03-21 1973-11-02 Inst Rech Scient Pyridoxine p-chlorophenoxyisobutyrate prodn - giving very pure product from corresp acid and pyridoxine
JPS5018470A (da) * 1973-05-31 1975-02-26
FR2260330A1 (en) 1974-02-07 1975-09-05 Innothera Lab Sa Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
CH607773A5 (en) * 1974-12-24 1978-10-31 Steigerwald Arzneimittelwerk Process for the preparation of novel pyridoxine derivatives
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2349330A1 (fr) * 1976-04-29 1977-11-25 Savini Emile Composition destinee au traitement des hyperlipidemies
JPS5347110A (en) * 1976-10-12 1978-04-27 Osaka Bosui Kensetsusha Kk Impermeable wall forming method

Also Published As

Publication number Publication date
EP0282696B1 (de) 1992-11-11
GR3006693T3 (da) 1993-06-30
DK55888A (da) 1988-08-19
DE3705549A1 (de) 1988-09-01
ATE82125T1 (de) 1992-11-15
DE3875760D1 (de) 1992-12-17
JPS63203621A (ja) 1988-08-23
JP2588686B2 (ja) 1997-03-05
EP0282696A3 (en) 1989-06-14
HUT47850A (en) 1989-04-28
EP0282696A2 (de) 1988-09-21
ES2052609T3 (es) 1994-07-16
JPH07238020A (ja) 1995-09-12
EG18335A (en) 1992-09-30
KR880009649A (ko) 1988-10-04
ZA88577B (en) 1988-07-28
CA1340246C (en) 1998-12-15
KR950009094B1 (ko) 1995-08-14
JPH0710777B2 (ja) 1995-02-08

Similar Documents

Publication Publication Date Title
DK55888A (da) Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose
KR950009098B1 (en) Pharmaceutical composition for use in treating clot formation
UA26890C2 (uk) Піримідиhові похідhі, що мають гербіцидhу активhість, спосіб їх отримаhhя, гербіцидhа композиція і спосіб зhищеhhя бур'яhів
IL129394A0 (en) Substituted aminoalkane phosphonic acids
DE69230526D1 (de) Polyaminosäure-dispergiermittel
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
BG49719A3 (en) Method for preparing of variants chirudine and their use
ATE22655T1 (de) Infusionsloesungen zur herztherapie.
ATE99118T1 (de) Biozide mittel und behandlungsverfahren.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO301767B1 (no) Salt av clavulansyre
AU8806798A (en) Diphosphonic acid salts for the treatment of osteoporosis
GR3019866T3 (en) Medicament for treating hyperlipidaemia and/or atherosclerosis
NO891423D0 (no) Ikke-klumpdannende produkter, sammensetninger og behandlinger for salter, enkle og komplekse gjoedningsstoffer.
EP0355612A3 (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
HU9200025D0 (en) Medical preparations for treating depression
GB8603962D0 (en) Chemical compositions
DK0514789T3 (da)
DK786A (da) 1,3,4-trisubstituerede azacycloalkaner og azacycloalkener og salte deraf samt deres fremstilling og anvendelse
ATE64852T1 (de) Stabile 5-fluorouracil-formulierungen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment